Eli Lilly Stock Hovers In Buy Zone, Finds Key Support Amid $3 Billion Deal

Eli Lilly (LLY) stock is testing its 10-week moving average as it takes a breather from the all-time high it hit this month. But the stock is also hovering in a buy zone just as prospects in the hot psychedelics and peptides markets crop up. The drugmaker's stock price has been improving since late April, with investors pushing into defensive…

Sinergia Empresarial continuará el seguimiento de esta información sobre eli Lilly Stock Hovers In Buy Zone, Finds Key Support Amid $3 Billion Deal y ampliará la cobertura conforme se confirmen nuevos elementos relevantes para el ecosistema empresarial.